Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

AIDS Research and Human Retroviruses, Ahead of Print.

Source: AIDS Research and Human Retroviruses - October 20, 2019 Category: Infectious Diseases Authors: Erkki Lathouwers Eric Y Wong Kimberley Brown Bryan Baugh Anne Ghys John Jezorwski El Ghazi Mohsine Erika Van Landuyt Magda Opsomer Sandra De Meyer Source Type: research